Find out more about our Academic Medical Centre and efforts in Academic Medicine
Academic Medicine Executive Committee (AM EXCO)
Find out more about what JOAM do to support AM initiatives
Find out more about the Office of Duke-NUS Affairs and Study Trip to Duke Durham
Guidelines, forms, and templates for Academic Medicine.
Meet the New Academic Chair for SingHealth Duke-NUS Oncology Academic Clinical Programme (ONCO ACP)
Please join us in welcoming Professor Lim Soon Thye as the newly appointed Academic Chair,
SingHealth Duke-NUS Oncology Academic Clinical Programme (ONCO ACP) and Chief Executive Officer (CEO), National Cancer Centre Singapore (NCCS), effective from 1 December 2023.Professor Lim Soon Thye is a medical oncologist by training and an accomplished clinician leader who has demonstrated exceptional leadership in his multiple clinical and research leadership roles. He is currently the Deputy Group Chief Executive Officer (Research & Education), SingHealth and Associate Dean, Doctor of Medicine (MD) Programmes, Duke-NUS. Since 2015, he was conferred the distinguished Tanoto Foundation Professorship in Medical Oncology in recognition of his pioneering work on the genetic basis of cancers prevalent in Asia.Given Professor Lim’s strong leadership track record, outstanding academic credentials, and his unwavering commitment to excellence, he is well-poised to build on the strong foundations laid by Professor William Hwang and elevate ONCO ACP’s academic medicine agenda to greater heights and advance NCCS’s pursuit of excellence in clinical service, education and research.
Find out more about the Key Appointment Holders of ONCO ACP at the
ONCO ACP Organisation Chart.
For more information on the key leadership transition at NCCS, please visit the
media release at the SingHealth Newsroom. You may also visit Prof William Hwang's
LinkedIn post to read more about his thoughts on the leadership transition and his aspirations for the future.
Stay updated on the latest leadership announcements and news at NCCS via the following social media platforms: